Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Oliceridine on Psychomotor Recovery After Day Surgery
ChiCTR2400092422Phase 4Recruiting
- Sponsor
- Ningbo No. 2 Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine in postoperative pain and Postoperative cognitive dysfunction (POCD) (2 arms), sponsored by Ningbo No. 2 Hospital. Primary endpoints: DSST score 30 minutes after anesthesia recovery, TMT-A score 30 minutes after anesthesia recovery and 2 more. Started Nov 2024; status: recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative painPostoperative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on ChiCTR2400092422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092422.